美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

11.33

-0.1400-1.22%

盤後：11.330.00000.00%16:05 EDT

成交量：7.98萬

成交額：92.75萬

市值：4.14億

市盈率：-3.00

高：12.31

開：11.76

低：11.27

收：11.47

資料載入中...

總覽公司新聞公告

Rapport Therapeutics, Inc.盤中異動快速跳水5.78%

Rapport Therapeutics, Inc.盤中異動快速跳水5.03%報10.20美元

Rapport Therapeutics, Inc.盤中異動股價大跌5.09%報11.18美元

Rapport Therapeutics, Inc.盤中異動快速下跌5.06%

Rapport Therapeutics, Inc.盤中異動急速拉昇5.52%報13.38美元

Rapport Therapeutics, Inc.盤中異動下午盤大幅下跌5.13%報13.32美元

Rapport Therapeutics, Inc.盤中異動股價大跌5.03%報15.10美元

Rapport Therapeutics, Inc.盤中異動股價大漲5.23%報16.60美元

Rapport Therapeutics, Inc.盤中異動下午盤急速下挫5.05%報15.60美元

Rapport Therapeutics, Inc.盤中異動早盤股價大跌5.34%

Rapport Therapeutics, Inc.盤中異動股價大跌5.43%報16.81美元

Rapport Therapeutics, Inc.盤中異動股價大漲5.72%

Rapport Therapeutics, Inc.盤中異動大幅下挫6.28%

Rapport Therapeutics, Inc.盤中異動早盤快速拉昇5.12%報16.43美元

Rapport Therapeutics, Inc.盤中異動股價大漲5.34%報15.20美元

Rapport Therapeutics, Inc.盤中異動下午盤股價大漲5.01%

Rapport Therapeutics, Inc.盤中異動快速下跌5.76%

Rapport Therapeutics, Inc.盤中異動快速拉昇5.01%報14.47美元

Rapport Therapeutics, Inc.盤中異動下午盤急速上漲5.35%

Rapport Therapeutics, Inc.盤中異動臨近收盤股價大漲5.36%報13.37美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RAPP/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":11.33,"timestamp":1746216000000,"preClose":11.47,"halted":0,"volume":79809,"hourTrading":{"tag":"盘后","latestPrice":11.33,"preClose":11.33,"latestTime":"16:05 EDT","volume":681,"amount":7715.73,"timestamp":1746216310622},"delay":0,"floatShares":14750261,"shares":36496437,"eps":-3.775953,"marketStatus":"休市中","change":-0.14,"latestTime":"05-02 16:00:00 EDT","open":11.76,"high":12.3101,"low":11.27,"amount":927515.597087,"amplitude":0.09068,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.775953,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":11.47,"preHourTrading":{"tag":"盘前","latestPrice":11.47,"preClose":11.47,"latestTime":"04:22 EDT","volume":4,"amount":46.32,"timestamp":1746174148162},"postHourTrading":{"tag":"盘后","latestPrice":11.33,"preClose":11.33,"latestTime":"16:05 EDT","volume":681,"amount":7715.73,"timestamp":1746216310622},"volumeRatio":0.5211982292158605,"impliedVol":0.7198,"impliedVolPercentile":0.5545},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":14750261,"roa":"-22.07%","roe":"-35.09%","lyrEps":-3.775953,"volumeRatio":0.5211982292158605,"shares":36496437,"dividePrice":0,"high":12.3101,"amplitude":0.09068,"preClose":11.47,"low":11.27,"week52Low":6.43,"pbRate":"1.35","week52High":29.74,"institutionHeld":0,"latestPrice":11.33,"eps":-3.775953,"divideRate":0,"volume":79809,"delay":0,"ttmEps":-3.775953,"open":11.76,"prevYearClose":17.74,"prevWeekClose":10.62,"prevMonthClose":11.45,"prevQuarterClose":10.03,"fiveDayClose":10.62,"twentyDayClose":8.52,"sixtyDayClose":17.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516340206","title":"Rapport Therapeutics, Inc.盤中異動 快速跳水5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516340206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516340206?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 22:31","pubTimestamp":1741012315,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Rapport Therapeutics, Inc.股票出现异动，股价急速跳水5.78%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.17%、23.41%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为11.70%、9.55%、9.35%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231559637ac09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231559637ac09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2516937063","title":"Rapport Therapeutics, Inc.盤中異動 快速跳水5.03%報10.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516937063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516937063?lang=zh_tw&edition=fundamental","pubTime":"2025-03-01 02:06","pubTimestamp":1740765996,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时06分，Rapport Therapeutics, Inc.股票出现波动，股价急速下挫5.03%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301020636a2583559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301020636a2583559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2514862502","title":"Rapport Therapeutics, Inc.盤中異動 股價大跌5.09%報11.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514862502?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 04:13","pubTimestamp":1740600826,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时13分，Rapport Therapeutics, Inc.股票出现波动，股价急速跳水5.09%。截至发稿，该股报11.18美元/股，成交量21.0055万股，换手率0.57%，振幅8.32%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270413469893e853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270413469893e853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2514003019","title":"Rapport Therapeutics, Inc.盤中異動 快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514003019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514003019?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 00:23","pubTimestamp":1740500639,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时23分，Rapport Therapeutics, Inc.股票出现异动，股价快速下挫5.06%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1331.76%、1114.37%、902.45%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260023599892645f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260023599892645f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2514708900","title":"Rapport Therapeutics, Inc.盤中異動 急速拉昇5.52%報13.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514708900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514708900?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 03:54","pubTimestamp":1740426886,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时54分，Rapport Therapeutics, Inc.股票出现波动，股价快速拉升5.52%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为324.89%、139.35%、40.20%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035446989134fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035446989134fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","RAPP"],"gpt_icon":0},{"id":"2512353514","title":"Rapport Therapeutics, Inc.盤中異動 下午盤大幅下跌5.13%報13.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512353514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512353514?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 02:57","pubTimestamp":1739991465,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时57分，Rapport Therapeutics, Inc.股票出现波动，股价急速下跌5.13%。截至发稿，该股报13.32美元/股，成交量4.4918万股，换手率0.12%，振幅8.90%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220025745abd52e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220025745abd52e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","RAPP"],"gpt_icon":0},{"id":"2512169270","title":"Rapport Therapeutics, Inc.盤中異動 股價大跌5.03%報15.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512169270?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 23:17","pubTimestamp":1739891876,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时17分，Rapport Therapeutics, Inc.股票出现波动，股价急速下挫5.03%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Allogene Therapeutics, Inc.、Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为353.35%、135.13%、128.47%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Allogene Therapeutics, Inc.，振幅分别为148.75%、51.40%、50.49%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182317569627a049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182317569627a049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","BK4139","LENZ"],"gpt_icon":0},{"id":"2511691391","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲5.23%報16.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511691391?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 22:55","pubTimestamp":1739544901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时55分，Rapport Therapeutics, Inc.股票出现异动，股价大幅上涨5.23%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2034.72%、525.34%、439.22%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、40.35%、33.28%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225501962320e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225501962320e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2510359564","title":"Rapport Therapeutics, Inc.盤中異動 下午盤急速下挫5.05%報15.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510359564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510359564?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 03:16","pubTimestamp":1739301384,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日03时16分，Rapport Therapeutics, Inc.股票出现异动，股价快速下跌5.05%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.82%。其相关个股中，Omega Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3114.20%、1474.72%、496.14%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、72.23%、58.60%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120316249881eb04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120316249881eb04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RAPP","LENZ"],"gpt_icon":0},{"id":"2509723119","title":"Rapport Therapeutics, Inc.盤中異動 早盤股價大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509723119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509723119?lang=zh_tw&edition=fundamental","pubTime":"2025-02-08 00:04","pubTimestamp":1738944296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时04分，Rapport Therapeutics, Inc.股票出现波动，股价大幅下跌5.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208000456961b4986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208000456961b4986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2509258020","title":"Rapport Therapeutics, Inc.盤中異動 股價大跌5.43%報16.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509258020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509258020?lang=zh_tw&edition=fundamental","pubTime":"2025-02-06 03:30","pubTimestamp":1738783853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时30分，Rapport Therapeutics, Inc.股票出现波动，股价急速下跌5.43%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.43%。其相关个股中，Invivyd, Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4634.89%、2351.22%、1754.39%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、67.19%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206033054a23ab958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206033054a23ab958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2509460316","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509460316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509460316?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 02:12","pubTimestamp":1738692750,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日02时12分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨5.72%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1776.92%、968.55%、576.68%，振幅较大的相关个股有Azitra Inc、Cingulate Inc C/Wts 10/12/2026 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、57.14%、52.61%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205021230987a6c7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205021230987a6c7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2508144306","title":"Rapport Therapeutics, Inc.盤中異動 大幅下挫6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508144306?lang=zh_tw&edition=fundamental","pubTime":"2025-02-03 22:48","pubTimestamp":1738594139,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时48分，Rapport Therapeutics, Inc.股票出现异动，股价快速下挫6.28%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为423.44%、359.64%、226.14%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.，振幅分别为88.68%、50.76%、36.85%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032248599879721a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032248599879721a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2507624256","title":"Rapport Therapeutics, Inc.盤中異動 早盤快速拉昇5.12%報16.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507624256?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 22:50","pubTimestamp":1738248619,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时50分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1131.50%、153.00%、130.77%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Alterity Therapeutics Limited，振幅分别为56.41%、41.30%、36.77%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225019a234587b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225019a234587b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0},{"id":"2507634744","title":"Rapport Therapeutics, Inc.盤中異動 股價大漲5.34%報15.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507634744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507634744?lang=zh_tw&edition=fundamental","pubTime":"2025-01-29 22:47","pubTimestamp":1738162072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时47分，Rapport Therapeutics, Inc.股票出现波动，股价大幅上涨5.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922475298760c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922475298760c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4139","BK4007"],"gpt_icon":0},{"id":"2507542613","title":"Rapport Therapeutics, Inc.盤中異動 下午盤股價大漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507542613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507542613?lang=zh_tw&edition=fundamental","pubTime":"2025-01-29 02:41","pubTimestamp":1738089717,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日02时41分，Rapport Therapeutics, Inc.股票出现波动，股价快速上涨5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129024157abbb9737&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129024157abbb9737&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2506591588","title":"Rapport Therapeutics, Inc.盤中異動 快速下跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506591588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506591588?lang=zh_tw&edition=fundamental","pubTime":"2025-01-28 01:44","pubTimestamp":1737999879,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时44分，Rapport Therapeutics, Inc.股票出现异动，股价急速下跌5.76%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Allarity Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为2109.71%、250.57%、236.71%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 ，振幅分别为85.35%、65.16%、61.25%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280144409612562b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280144409612562b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","RAPP"],"gpt_icon":0},{"id":"2505234950","title":"Rapport Therapeutics, Inc.盤中異動 快速拉昇5.01%報14.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505234950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505234950?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 04:25","pubTimestamp":1737663907,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时25分，Rapport Therapeutics, Inc.股票出现波动，股价急速上涨5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7407.81%、7341.65%、1156.33%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为948.57%、261.32%、172.73%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042507960e8475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124042507960e8475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2505370382","title":"Rapport Therapeutics, Inc.盤中異動 下午盤急速上漲5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505370382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505370382?lang=zh_tw&edition=fundamental","pubTime":"2025-01-23 03:59","pubTimestamp":1737575953,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时59分，Rapport Therapeutics, Inc.股票出现波动，股价急速上涨5.35%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123035913a22bf5a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123035913a22bf5a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4139","BK4007"],"gpt_icon":0},{"id":"2505781955","title":"Rapport Therapeutics, Inc.盤中異動 臨近收盤股價大漲5.36%報13.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505781955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505781955?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 04:38","pubTimestamp":1737491918,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时38分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.36%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1669.53%、529.10%、191.52%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、69.14%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043838abb3938c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043838abb3938c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RAPP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"盤前","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2024-11-07","symbol":"RAPP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2025-05-02","current":-5.345807,"percent":0.782609,"low":-18.456468,"twenty":-13.651898,"median":-10.548248,"eighty":-5.303861,"high":-1.238107,"avg":-9.996797,"sd":4.10499,"marketCap":418614132},"quantilePoints":[{"date":"2024-06-07","current":-11.721364,"twenty":-11.721364,"median":-11.721364,"eighty":-11.721364,"marketCap":601399769},{"date":"2024-06-14","current":-15.892791,"twenty":-16.325792,"median":-15.672154,"eighty":-13.81742,"marketCap":815427333},{"date":"2024-06-21","current":-15.811683,"twenty":-18.036085,"median":-15.892791,"eighty":-15.139866,"marketCap":811265816},{"date":"2024-06-28","current":-16.346343,"twenty":-18.021611,"median":-15.892791,"eighty":-15.672154,"marketCap":838698159},{"date":"2024-07-05","current":-16.610109,"twenty":-18.028848,"median":-16.581593,"eighty":-15.672154,"marketCap":852231448},{"date":"2024-07-12","current":-18.456468,"twenty":-18.064817,"median":-16.682383,"eighty":-15.783777,"marketCap":946964471},{"date":"2024-07-15","current":-18.299635,"twenty":-18.092899,"median":-16.754656,"eighty":-15.811683,"marketCap":938917651},{"date":"2024-08-02","current":-14.614044,"twenty":-18.085878,"median":-16.682383,"eighty":-15.70006,"marketCap":749817368},{"date":"2024-08-09","current":-10.772462,"twenty":-18.050559,"median":-16.581593,"eighty":-14.719551,"marketCap":678859041},{"date":"2024-08-16","current":-11.828814,"twenty":-17.877609,"median":-15.852237,"eighty":-12.152035,"marketCap":745428193},{"date":"2024-08-23","current":-12.310557,"twenty":-17.253126,"median":-15.672154,"eighty":-12.113216,"marketCap":775786652},{"date":"2024-08-30","current":-11.492174,"twenty":-17.046391,"median":-14.856424,"eighty":-11.831136,"marketCap":724213848},{"date":"2024-09-06","current":-12.316361,"twenty":-16.995064,"median":-14.477739,"eighty":-11.828814,"marketCap":776152417},{"date":"2024-09-13","current":-10.975607,"twenty":-16.754656,"median":-13.041877,"eighty":-11.712731,"marketCap":691660801},{"date":"2024-09-20","current":-11.75336,"twenty":-16.610109,"median":-12.73716,"eighty":-11.45735,"marketCap":740673254},{"date":"2024-09-27","current":-11.915876,"twenty":-16.610109,"median":-12.415031,"eighty":-11.492174,"marketCap":750914662},{"date":"2024-10-04","current":-10.644772,"twenty":-16.581593,"median":-12.319263,"eighty":-11.45735,"marketCap":670812221},{"date":"2024-10-11","current":-11.846226,"twenty":-16.346343,"median":-12.304752,"eighty":-11.439937,"marketCap":746525487},{"date":"2024-10-18","current":-16.28058,"twenty":-16.346343,"median":-12.319263,"eighty":-11.45735,"marketCap":1025969618},{"date":"2024-10-25","current":-14.411651,"twenty":-16.28058,"median":-12.415031,"eighty":-11.492174,"marketCap":908193427},{"date":"2024-10-31","current":-15.578281,"twenty":-15.970349,"median":-12.705237,"eighty":-11.650047,"marketCap":981712105},{"date":"2024-11-08","current":-13.694662,"twenty":-15.827905,"median":-12.870655,"eighty":-11.708088,"marketCap":983906693},{"date":"2024-11-15","current":-11.189913,"twenty":-15.754653,"median":-12.798103,"eighty":-11.650047,"marketCap":803950524},{"date":"2024-11-22","current":-11.464825,"twenty":-15.685802,"median":-12.664608,"eighty":-11.434133,"marketCap":823701811},{"date":"2024-11-29","current":-11.627735,"twenty":-15.672154,"median":-12.397619,"eighty":-11.395825,"marketCap":835406277},{"date":"2024-12-06","current":-10.319361,"twenty":-15.61583,"median":-12.322165,"eighty":-11.357915,"marketCap":741404783},{"date":"2024-12-13","current":-9.677901,"twenty":-15.33799,"median":-12.307654,"eighty":-11.16344,"marketCap":695318447},{"date":"2024-12-20","current":-9.092441,"twenty":-15.121845,"median":-12.218286,"eighty":-11.007144,"marketCap":653255522},{"date":"2024-12-27","current":-9.815356,"twenty":-15.075412,"median":-12.095804,"eighty":-10.933817,"marketCap":705194090},{"date":"2025-01-03","current":-9.362262,"twenty":-15.053587,"median":-12.072587,"eighty":-10.78291,"marketCap":672641044},{"date":"2025-01-10","current":-8.4968,"twenty":-15.021085,"median":-11.886855,"eighty":-10.451725,"marketCap":610461067},{"date":"2025-01-17","current":-6.368782,"twenty":-15.009476,"median":-11.834618,"eighty":-10.309179,"marketCap":457571477},{"date":"2025-01-24","current":-7.264789,"twenty":-14.781954,"median":-11.796891,"eighty":-9.793974,"marketCap":521946041},{"date":"2025-01-31","current":-8.476436,"twenty":-14.660068,"median":-11.755009,"eighty":-9.580154,"marketCap":608998009},{"date":"2025-02-07","current":-8.527345,"twenty":-14.639173,"median":-11.73446,"eighty":-9.397898,"marketCap":612655654},{"date":"2025-02-14","current":-8.028432,"twenty":-14.630244,"median":-11.689515,"eighty":-9.145387,"marketCap":576810726},{"date":"2025-02-21","current":-6.618238,"twenty":-14.619747,"median":-11.627735,"eighty":-9.042041,"marketCap":475493941},{"date":"2025-02-28","current":-5.467683,"twenty":-14.492608,"median":-11.461087,"eighty":-8.488654,"marketCap":392831148},{"date":"2025-03-07","current":-4.11349,"twenty":-14.373344,"median":-11.410917,"eighty":-8.297234,"marketCap":295537772},{"date":"2025-03-14","current":-4.670008,"twenty":-14.343983,"median":-11.35537,"eighty":-8.022323,"marketCap":365694298},{"date":"2025-03-21","current":-4.716615,"twenty":-14.310432,"median":-11.296823,"eighty":-7.313662,"marketCap":369343942},{"date":"2025-03-28","current":-4.520866,"twenty":-14.209667,"median":-11.0932,"eighty":-7.051987,"marketCap":354015438},{"date":"2025-04-04","current":-3.970905,"twenty":-14.097067,"median":-11.027844,"eighty":-6.777076,"marketCap":310949643},{"date":"2025-04-11","current":-4.022172,"twenty":-13.848651,"median":-10.975607,"eighty":-6.460419,"marketCap":314964251},{"date":"2025-04-17","current":-4.54883,"twenty":-13.703476,"median":-10.88248,"eighty":-6.145798,"marketCap":356205225},{"date":"2025-04-25","current":-5.173362,"twenty":-13.694662,"median":-10.772462,"eighty":-5.351373,"marketCap":405110450},{"date":"2025-05-02","current":-5.345807,"twenty":-13.651898,"median":-10.548248,"eighty":-5.303861,"marketCap":418614132}],"updateTime":1746334870538}}}